This video demonstrates a thoracoscopic right upper lobectomy, performed using the Harmonic HD as the main dissecting instrument.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
April 18, 2019
Fukui and colleagues retrospectively compared outcomes for patients who were either smokers (410 patients) or never smokers (256 patients) and who underwent resection for primary lung cancer (stage I to III). The authors evaluated 90-day mortality and respiratory complications, both of which were higher for smokers than for never smokers.
April 17, 2019
Dr Burt gives a brief overview of the considerable advances for patients with thoracic malignancies (non–small cell lung cancer in particular).
April 17, 2019
Buitrago and Restrepo report the largest series to date from Latin America of patients undergoing robot-assisted thoracic surgery. A total of 69 patients underwent robot-assisted procedures with 47 undergoing pulmonary resections, 18 undergoing mediastinal procedures, and 4 undergoing another type of operation.
April 12, 2019
Patient Care and General Interest
April 5, 2019
Patient Care and General Interest
In this brief video, an oncologist shares some thoughts on the value of tumor board discussions and the importance of having them early in a patient’s care.
Drugs and Devices
Intraoperative Conversion During Video-Assisted Thoracoscopy Does Not Constitute a Treatment Failure
April 3, 2019
Intraoperative conversion may be necessary during video-assisted thoracoscopic surgery (VATS) for lung cancer. In this study on 610 patients, Fourdrain and colleagues observed that conversion during a VATS procedure was not associated with worse outcomes than undergoing an up-front thoracotomy.
March 29, 2019
Patient Care and General Interest
March 28, 2019
Sun and colleagues investigated the relationship between low skeletal muscle mass and the prognosis of early-stage non–small cell lung cancer (NSCLC).
March 16, 2019
The institution-specific uptake of VATS for lung cancer resection in the US Veterans Affairs system was evaluated over the past 15 years. Uptake more than tripled during the study period, with a current mean of more than 50% among institutions. However, uptake ranged from 0 to 82% and was associated with increasing center volume.